Infusing AI in Clinical Trials: Meri Beckwith from Lindus Health in Conversation with PharmaShots

Shots: Meri Beckwith, Co-Founder of Lindus Health engages in a striking conversation with PharmaShots Meri talks about bridging the gaps of clinical trials in CNS/Neurology by leveraging LLMs that are trained on nearly a million clinical trial protocols and simple machine learning models to monitor real-time clinical trial data Meri highlights the importance of multidisciplinary…

BySaurabh ChaubeyMay 8, 2024

THOUGHTSPOT

A Peek into the US Healthcare System

Shots: The US contributes significantly to the healthcare budget but still registers unfavorable healthcare outcomes owing to health inequality and healthcare disparities The Land of Opportunities registers 46.2M immigrants and nearly half of the undocumented immigrants lack basic healthcare The article covers the historical journey of US healthcare with takes on a few public healthcare programs adopted by the…

BySaurabh ChaubeyMay 7, 2024

VIEWPOINTS

Takeda at AAAAI 2024: Salomé Juethner highlights P-IV Results from ENABLE and EMPOWER Studies

Shots: At the American Academy of Allergy, Asthma, & Immunology (AAAAI), Takeda presented 9 abstracts focusing on health equity and real-world data from P-IV (ENABLE) & (EMPOWER) studies evaluating HAE patients Salomé Juethner, Senior Medical Director-Head of Rare Genetics at Takeda, in a stimulating conversation with PharmaShots, talks about shares insights from the real-world P-IV…

BySaurabh ChaubeyMay 6, 2024

INSIGHTS+

Insights+: An Analysis of the Growth of Biopharma Companies in the Last 20 Years (2004-2023)

Shots: Witness the journey of the biopharma companies over 20 years with this informative and engaging report. The report highlights the development of the biopharma industry and the key factors influencing them In 2023, JNJ reclaims the topmost position in the list from Pfizer with a revenue of $85.16B, showcasing a sharp 10.30 percent vs…

BySaurabh ChaubeyMay 1, 2024

VIEWPOINTS

Transformative Neurodegenerative Disorder Care: Angela Cacace in Conversation with PharmaShots

Shots: Angela Cacace Sr. VP, of Neuroscience and Platform Biology at Arvinas, shares insights from the preclinical trials evaluating ARV-102 for treatment of neurodegenerative diseases and dosing people with the first oral formulation (ARV-102) to treat neurodegenerative diseases ARV-102, a novel oral PROTAC® protein degrader, is designed to cross the blood-brain barrier and target leucine-rich repeat kinase…

BySaurabh ChaubeyApril 29, 2024

VIEWPOINTS

Technology Infusion: Raviv Pryluk Sheds Light on PhaseV’s Recent Collaboration with 9xchange Biopharma Marketplace

Shots: Raviv Pryluk, CEO and Co-Founder of PhaseV, in a stimulating conversation with PharmaShots, sheds light on the company’s recent partnership with 9xchange Biopharma The partnership aims to bring Phase V’s proprietary machine learning (ML) technology to ecosystem members, enabling them, to retrospectively analyze and optimally design and execute advanced clinical studies Raviv highlights the…

BySaurabh ChaubeyApril 23, 2024

INSIGHTS+

Disease of the Month – Duchenne Muscular Dystrophy (DMD)

Shots: The Disease of the Month report by PharmaShots aims to integrate an advanced approach to disease analysis. The report delves deep into the epidemiology, market size, disease management, available therapies, and key players involved For the April edition of the Disease of the Month report, PharmaShots brings an enlightening guide to Duchenne Muscular Dystrophy,…

BySaurabh ChaubeyApril 17, 2024

VIEWPOINTS

Expanding Services: Mo Jain Sheds Light on Sapient’s Recently Launched Discovery Proteomics Services

Shots: Following the roll-out of high throughput discovery proteomics services, Mo Jain, Founder and CEO of Sapient engages in a stimulating conversation with PharmaShots Unlike conventional mass spectrometry-based proteomics methodologies in the market, Sapient’s Discovery Proteomics Services leverage the nanoparticle enrichment technology to measure more proteins and PTMs within the plasma proteome While highlighting Sapient’s…

BySaurabh ChaubeyApril 16, 2024

VIEWPOINTS

Bayer at ASCO GU: Neal Shore Speaking about Nubeqa with PharmaShots

Shots: At ASCO GU, Bayer presented new data from its Oncology portfolio. The analysis revolved around NUBEQA (darolutamide), which is currently approved in the US in combination with docetaxel for the treatment of mHSPC and nmCRPC in adults Neal Shore in conversation with PharmaShots initiated the discussion by familiarizing our audience with the ARASENS P-III…

BySaurabh ChaubeyApril 10, 2024

THOUGHTSPOT

Your Guide to Conference Coverage in the Healthcare Industry

Shots: An ocean of knowledge, an aggregation of thought leaders, and an assembly of pharma enthusiasts like us, healthcare Conferences are turning out to be the cornerstone of ideas, learning, and most importantly, a budding spot for networking with like-minded people Conference coverage can be a convoluted task and requires immense planning before, at, and…

BySaurabh ChaubeyApril 9, 2024

Saurabh Chaubey

Infusing AI in Clinical Trials: Meri Beckwith from Lindus Health in Conversation with PharmaShots

A Peek into the US Healthcare System

Takeda at AAAAI 2024: Salomé Juethner highlights P-IV Results from ENABLE and EMPOWER Studies

Insights+: An Analysis of the Growth of Biopharma Companies in the Last 20 Years (2004-2023)

Transformative Neurodegenerative Disorder Care: Angela Cacace in Conversation with PharmaShots

Technology Infusion: Raviv Pryluk Sheds Light on PhaseV’s Recent Collaboration with 9xchange Biopharma Marketplace

Disease of the Month – Duchenne Muscular Dystrophy (DMD)

Expanding Services: Mo Jain Sheds Light on Sapient’s Recently Launched Discovery Proteomics Services

Bayer at ASCO GU: Neal Shore Speaking about Nubeqa with PharmaShots

Your Guide to Conference Coverage in the Healthcare Industry

Contact US

FOLLOW US